This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Thursday's Health Winners & Losers

Elsewhere, Ariad Pharmaceuticals (ARIA - Get Report) entered into a non-exclusive license agreement with cardiovascular device company Icon Medical, to develop and commercialize drug-eluting stents that deliver Ariad's novel mTOR inhibitor, deforolimus, to prevent re-narrowing of arteries after interventions in which stents are used with balloon angioplasty.

Icon is responsible for development and commercialization. Ariad is receiving an equity stake in Icon, up to $27 million in payments based on achievement of certain clinical, regulatory and commercial milestones for two products and royalties on all sales of Icon medical devices that deliver deforolimus. Additional terms weren't disclosed. Ariad shares edged down 12 cents, or 2.3%, to $5.01.

3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
NPSP $45.97 0.02%
NOVC $0.40 0.00%
ARIA $8.99 0.00%
COR $46.07 0.00%
MNTA $18.80 0.00%

Markets

DOW 17,928.20 -142.20 -0.79%
S&P 500 2,089.46 -25.03 -1.18%
NASDAQ 4,939.3270 -77.6020 -1.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs